Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Amneal Pharmaceuticals, Inc.

Amneal Pharmaceuticals, Inc. (AMRX) Stock Overview

Explore Amneal Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

AMRX●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$18.10
$0.60(3.43%)
U.S. Market opens in 16h 35m

Amneal Pharmaceuticals, Inc. (AMRX)

Meyka AI Score

Z

Key Financials

Market Cap5.8B
P/E Ratio46.45
EPS (TTM)$0.90
ROE-1.45%
Fundamental Analysis

AI Price Forecasts

1 Month$18.50
3 Months$18.92
1 Year Target$19.15

AMRX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Amneal Pharmaceuticals, Inc. (AMRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.53, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $19.15.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 46.45 and a market capitalization of 5.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.43%
5-Day Change
3.25%
1-Month Change
12.35%
3-Month Change
39.02%
6-Month Change
32.02%
Year-to-Date (YTD) Change
43.65%
1-Year Change
128.82%
3-Year Change
437.09%
5-Year Change
279.45%
All-Time (Max) Change
281.05%

Contact Information

https://www.amneal.com
908 947 3120
400 Crossing Boulevard, Bridgewater, NJ, 08807

Company Facts

85,000 Employees
IPO DateMay 7, 2018
CountryUS
Actively Trading

Frequently Asked Questions